A new government-run discount medicine website is set to launch this month. It's called TrumpRx: A direct-to-consumer drug sale website created by President Donald Trump's administration. The program ...

The year ahead promises major developments in some of the most closely watched mass tort cases. Courts are likely to issue ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

Another mass tort to watch in 2026 involves Bayer’s widely used weedkiller Roundup and allegations that its active ingredient, glyphosate, can cause cancer. Tens of thousands of plaintiffs have filed ...

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed that ...

Eli Lilly’s crop of new products propelled the company to 8% sales growth in the fourth quarter, but the most pleasing aspect for the firm was likely the resilience of its diabetes blockbuster ...

And this here’s a list of things I'd like to see disappear in 2026: Seed-oil paranoia – Seed-oils are not toxic or dangerous ...

Maryland’s Prescription Drug Affordability Board (PDAB) serves as a bellwether for how other states may address high drug ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications including ...